Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of MOMENT ACT ANALGESIC Granules in Healthy Volunteers
NCT02482155Phase 1Completed
- Sponsor
- Angelini Pharma
- Start
- Feb 2015
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ibuprofen in pain, sponsored by Angelini Pharma. Primary endpoints: Maximum Plasma Concentration, Area Under the Curve and 5 more. Started Feb 2015; status: completed.
02
Drugs
ibuprofen
03
Conditions
pain
Beyond the preview
Go deeper on NCT02482155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02482155.